This will play a video - Five clinicians sit in discussion at a table

Superficial Vein Therapies

Help your patients find relief from chronic venous insufficiency.
Explore Products

Chronic Venous Insufficiency

Venous reflux is a progressive condition that left untreated can lead to chronic venous insufficiency (CVI).

More on CVI

VenaSeal Closure System

Simple innovations to the VenaSeal™ closure system mean greater* impact for you and your practice, and the same great outcomes you expect — such as a demonstrated 94.6% closure rate at 5 years.1-3

Learn More

ClosureFast Procedure

The ClosureFast™ procedure, with its patented overlap design, is the only RFA procedure with published clinical data demonstrating long-term safety and efficacy, with a 91.9% closure rate at 5 years.4,5

Learn about ClosureFast

Clinical Evidence

See clinical evidence for our superficial vein therapy products.

See Evidence

Resources and Support

Find product, condition, and patient education materials.

Find Resources

Connect With Us

Connect with a Medtronic representative and sign up for ongoing updates.

Connect with Us
VenaSeal closure system on light blue gradient background

Explore Products

Learn more about our superficial vein products.

See Products
ClosureFast radiofrequency ablation system on gradient background
*

All statements of being “greater” are as compared to previous version and procedure technique.

References

1

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. March 2021;9(2):329-334.

2

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. September 2017;5(5):658-666.

3

Morrison N, Gibson K, Vasquez M, et al. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. November 2020;8(6):978-989.

4

Proebstle TM, Alm BJ, Göckeritz O, et al. Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins. Br J Surg. February 2015;102(3):212-218.

5

ClosureFast and ClosureFast RFS Patents. Available at www.medtronic.com/patents. Accessed March 9, 2021.